Delivery Order SPE2DB20D2014-SPE2DB25FA67J
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the Defense Logistics Agency (DLA) with 4566582548 units of the drug RESTASIS 0.05% eye emulsion. The contract is a delivery order with a firm fixed price of $1,325.95 and a completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply RESTASIS 0.05% eye emulsion to the U.S. government. The Delivery Order contract, valued at $4,363.48, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 31, 2024. This contract is not set-aside and is awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The award, valued at $1,080.48, was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with the company worth up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $6,549.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a specialty medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, through the Defense Logistics Agency (DLA) Troop Support Medical, provides for the delivery of the pharmaceutical product RESTASIS 0.05% Eye Emulsion 30S. The contract has a ceiling value of $18,004.95 and an ultimate completion date of September 19, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of RESTASIS 0.05% eye emulsion. The $7,420.01 firm fixed-price delivery order was awarded on June 29, 2022, with a completion date of June 30, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,262.57 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RESTASIS 0.05% Eye Emulsion, a prescription pharmaceutical product, with a performance period ending on April 24, 2024. This Delivery Order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and...
This federal contract award is a delivery order valued at $2,352.00 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a prescription ophthalmic medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $11,648.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a completion date of October 21, 2024.
The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.38 firm-fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a specialty medication used to treat dry eye disease. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...